Clinical Trials · NCT02860923
Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- University Hospital, Bordeaux
- Enrollment
- 42
- Start date
- Jan 2017
- Locations
- 11 sites, France
- Primary endpoint
- Compare body weight change thanks to weighing machine